0000891293-15-000070.txt : 20151218 0000891293-15-000070.hdr.sgml : 20151218 20151218164158 ACCESSION NUMBER: 0000891293-15-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151218 FILED AS OF DATE: 20151218 DATE AS OF CHANGE: 20151218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER JACK W CENTRAL INDEX KEY: 0001204264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151297259 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-12-18 0 0000891293 CTI BIOPHARMA CORP ctic 0001204264 SINGER JACK W 3101 WESTERN AVE SUITE 600 SEATTLE WA 98121 1 1 0 0 EVP Global Medical Affairs Common Stock 2015-12-18 4 S 0 1904 1.17 D 1319946 D Common Stock 2015-12-18 4 S 0 2000 1.175 D 1317946 D Common Stock 2015-12-18 4 S 0 10696 1.18 D 1307250 D Common Stock 2015-12-18 4 S 0 400 1.185 D 1306850 D The sale was effected pursuant to a Rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: Jack W. Singer 2015-12-18